![]() 腎臓結石の世界市場 2022-2026Global Kidney Stones Market 2022-2026 腎臓結石の世界市場 2022-2026 Technavioは腎臓結石市場を監視しており、2022年から2026年の間に4億1609万ドルの成長が見込まれ、予測期間中にCAGR6.69%で進行しているとのことです。当レポートでは、腎臓結石市... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー腎臓結石の世界市場 2022-2026Technavioは腎臓結石市場を監視しており、2022年から2026年の間に4億1609万ドルの成長が見込まれ、予測期間中にCAGR6.69%で進行しているとのことです。当レポートでは、腎臓結石市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。 現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、デジタル軟性尿管鏡の普及と尿路結石症の発生率の上昇によって牽引されています。また、デジタル軟性尿管鏡の普及が進んでいることも、市場の成長を後押しすると予想されます。 腎臓結石市場の分析には、タイプ別セグメントと地理的展望が含まれます。 Technavioの腎臓結石市場は、以下のようにセグメント化されています。 タイプ別 - サイアザイド系利尿剤 - 鎮痛剤 - 抗生物質 - その他 地域別状況 - 北米 - 欧州 - アジア - 列 本調査では、今後数年間の腎臓結石市場の成長を促進する主要な理由の1つとして、腎臓結石疾患の有病率の増加を挙げています。 Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な図を提示します。腎臓結石市場に関する弊社のレポートは、以下の分野を対象としています。 - 腎臓結石市場のサイジング - 腎臓結石市場予測 - 腎臓結石市場の産業分析 Technavioの強固なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Aristo Pharma GmbH、Bausch Health Companies Inc、Bayer AG、Cipla Inc、Dr. Reddys Laboratories Ltd、Emcure Pharmaceuticals Ltd、GlaxoSmithKline Plc、Intas Pharmaceuticals Ltd、Macleods Pharmaceuticals Ltd、Pfizer Incなど複数の腎結石市場の主要ベンダーに関する詳細分析を掲載しています。また、腎臓結石市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。 本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/kidney-stones-market-industry-analysis をご覧ください。 Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。 目次• Executive Summaryo Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2021 o Market outlook: Forecast for 2021 - 2026 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Type o Market segments o Comparison by Type o Thiazide diuretic - Market size and forecast 2021-2026 o Pain relievers - Market size and forecast 2021-2026 o Antibiotics - Market size and forecast 2021-2026 o Others - Market size and forecast 2021-2026 o Market opportunity by Type • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2021-2026 o Europe - Market size and forecast 2021-2026 o Asia - Market size and forecast 2021-2026 o ROW - Market size and forecast 2021-2026 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Aristo Pharma GmbH o Bausch Health Companies Inc. o Bayer AG o Cipla Inc. o Dr. Reddys Laboratories Ltd. o Emcure Pharmaceuticals Ltd. o GlaxoSmithKline Plc o Intas Pharmaceuticals Ltd. o Macleods Pharmaceuticals Ltd. o Pfizer Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2021 - 2026 ($ million) • 13: Global market: Year-over-year growth 2021 - 2026 (%) • 14: Five forces analysis 2021 & 2026 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2021 • 21: Type - Market share 2021-2026 (%) • 22: Comparison by Type • 23: Thiazide diuretic - Market size and forecast 2021-2026 ($ million) • 24: Thiazide diuretic - Year-over-year growth 2021-2026 (%) • 25: Pain relievers - Market size and forecast 2021-2026 ($ million) • 26: Pain relievers - Year-over-year growth 2021-2026 (%) • 27: Antibiotics - Market size and forecast 2021-2026 ($ million) • 28: Antibiotics - Year-over-year growth 2021-2026 (%) • 29: Others - Market size and forecast 2021-2026 ($ million) • 30: Others - Year-over-year growth 2021-2026 (%) • 31: Market opportunity by Type • 32: Customer landscape • 33: Market share By Geographical Landscape 2021-2026 (%) • 34: Geographic comparison • 35: North America - Market size and forecast 2021-2026 ($ million) • 36: North America - Year-over-year growth 2021-2026 (%) • 37: Europe - Market size and forecast 2021-2026 ($ million) • 38: Europe - Year-over-year growth 2021-2026 (%) • 39: Asia - Market size and forecast 2021-2026 ($ million) • 40: Asia - Year-over-year growth 2021-2026 (%) • 41: ROW - Market size and forecast 2021-2026 ($ million) • 42: ROW - Year-over-year growth 2021-2026 (%) • 43: Key leading countries • 44: Market opportunity By Geographical Landscape ($ million) • 45: Impact of drivers and challenges • 46: Vendor landscape • 47: Landscape disruption • 48: Industry risks • 49: Vendors covered • 50: Market positioning of vendors • 51: Aristo Pharma GmbH - Overview • 52: Aristo Pharma GmbH - Product and service • 53: Aristo Pharma GmbH - Key offerings • 54: Aristo Pharma GmbH - Key customers • 55: Aristo Pharma GmbH - Segment focus • 56: Bausch Health Companies Inc. - Overview • 57: Bausch Health Companies Inc. - Business segments • 58: Bausch Health Companies Inc. - Key offerings • 59: Bausch Health Companies Inc. - Key customers • 60: Bausch Health Companies Inc. - Segment focus • 61: Bayer AG - Overview • 62: Bayer AG - Business segments • 63: Bayer AG - Key offerings • 64: Bayer AG - Key customers • 65: Bayer AG - Segment focus • 66: Cipla Inc. - Overview • 67: Cipla Inc. - Business segments • 68: Cipla Inc. - Key offerings • 69: Cipla Inc. - Key customers • 70: Cipla Inc. - Segment focus • 71: Dr. Reddys Laboratories Ltd. - Overview • 72: Dr. Reddys Laboratories Ltd. - Business segments • 73: Dr. Reddys Laboratories Ltd. - Key offerings • 74: Dr. Reddys Laboratories Ltd. - Key customers • 75: Dr. Reddys Laboratories Ltd. - Segment focus • 76: Emcure Pharmaceuticals Ltd. - Overview • 77: Emcure Pharmaceuticals Ltd. - Product and service • 78: Emcure Pharmaceuticals Ltd. - Key offerings • 79: Emcure Pharmaceuticals Ltd. - Key customers • 80: Emcure Pharmaceuticals Ltd. - Segment focus • 81: GlaxoSmithKline Plc - Overview • 82: GlaxoSmithKline Plc - Business segments • 83: GlaxoSmithKline Plc - Key offerings • 84: GlaxoSmithKline Plc - Key customers • 85: GlaxoSmithKline Plc - Segment focus • 86: Intas Pharmaceuticals Ltd. - Overview • 87: Intas Pharmaceuticals Ltd. - Product and service • 88: Intas Pharmaceuticals Ltd. - Key offerings • 89: Intas Pharmaceuticals Ltd. - Key customers • 90: Intas Pharmaceuticals Ltd. - Segment focus • 91: Macleods Pharmaceuticals Ltd. - Overview • 92: Macleods Pharmaceuticals Ltd. - Product and service • 93: Macleods Pharmaceuticals Ltd. - Key offerings • 94: Macleods Pharmaceuticals Ltd. - Key customers • 95: Macleods Pharmaceuticals Ltd. - Segment focus • 96: Pfizer Inc. - Overview • 97: Pfizer Inc. - Business segments • 98: Pfizer Inc. - Key offerings • 99: Pfizer Inc. - Key customers • 100: Pfizer Inc. - Segment focus • 101: Currency conversion rates for US$ • 102: Research Methodology • 103: Validation techniques employed for market sizing • 104: Information sources • 105: List of abbreviations
SummaryGlobal Kidney Stones Market 2022-2026 Table of Contents• Executive Summaryo Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2021 o Market outlook: Forecast for 2021 - 2026 • Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Type o Market segments o Comparison by Type o Thiazide diuretic - Market size and forecast 2021-2026 o Pain relievers - Market size and forecast 2021-2026 o Antibiotics - Market size and forecast 2021-2026 o Others - Market size and forecast 2021-2026 o Market opportunity by Type • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2021-2026 o Europe - Market size and forecast 2021-2026 o Asia - Market size and forecast 2021-2026 o ROW - Market size and forecast 2021-2026 o Key leading countries o Market opportunity By Geographical Landscape o Market drivers o Market challenges o Market trends • Vendor Landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Aristo Pharma GmbH o Bausch Health Companies Inc. o Bayer AG o Cipla Inc. o Dr. Reddys Laboratories Ltd. o Emcure Pharmaceuticals Ltd. o GlaxoSmithKline Plc o Intas Pharmaceuticals Ltd. o Macleods Pharmaceuticals Ltd. o Pfizer Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2021 - 2026 ($ million) • 13: Global market: Year-over-year growth 2021 - 2026 (%) • 14: Five forces analysis 2021 & 2026 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2021 • 21: Type - Market share 2021-2026 (%) • 22: Comparison by Type • 23: Thiazide diuretic - Market size and forecast 2021-2026 ($ million) • 24: Thiazide diuretic - Year-over-year growth 2021-2026 (%) • 25: Pain relievers - Market size and forecast 2021-2026 ($ million) • 26: Pain relievers - Year-over-year growth 2021-2026 (%) • 27: Antibiotics - Market size and forecast 2021-2026 ($ million) • 28: Antibiotics - Year-over-year growth 2021-2026 (%) • 29: Others - Market size and forecast 2021-2026 ($ million) • 30: Others - Year-over-year growth 2021-2026 (%) • 31: Market opportunity by Type • 32: Customer landscape • 33: Market share By Geographical Landscape 2021-2026 (%) • 34: Geographic comparison • 35: North America - Market size and forecast 2021-2026 ($ million) • 36: North America - Year-over-year growth 2021-2026 (%) • 37: Europe - Market size and forecast 2021-2026 ($ million) • 38: Europe - Year-over-year growth 2021-2026 (%) • 39: Asia - Market size and forecast 2021-2026 ($ million) • 40: Asia - Year-over-year growth 2021-2026 (%) • 41: ROW - Market size and forecast 2021-2026 ($ million) • 42: ROW - Year-over-year growth 2021-2026 (%) • 43: Key leading countries • 44: Market opportunity By Geographical Landscape ($ million) • 45: Impact of drivers and challenges • 46: Vendor landscape • 47: Landscape disruption • 48: Industry risks • 49: Vendors covered • 50: Market positioning of vendors • 51: Aristo Pharma GmbH - Overview • 52: Aristo Pharma GmbH - Product and service • 53: Aristo Pharma GmbH - Key offerings • 54: Aristo Pharma GmbH - Key customers • 55: Aristo Pharma GmbH - Segment focus • 56: Bausch Health Companies Inc. - Overview • 57: Bausch Health Companies Inc. - Business segments • 58: Bausch Health Companies Inc. - Key offerings • 59: Bausch Health Companies Inc. - Key customers • 60: Bausch Health Companies Inc. - Segment focus • 61: Bayer AG - Overview • 62: Bayer AG - Business segments • 63: Bayer AG - Key offerings • 64: Bayer AG - Key customers • 65: Bayer AG - Segment focus • 66: Cipla Inc. - Overview • 67: Cipla Inc. - Business segments • 68: Cipla Inc. - Key offerings • 69: Cipla Inc. - Key customers • 70: Cipla Inc. - Segment focus • 71: Dr. Reddys Laboratories Ltd. - Overview • 72: Dr. Reddys Laboratories Ltd. - Business segments • 73: Dr. Reddys Laboratories Ltd. - Key offerings • 74: Dr. Reddys Laboratories Ltd. - Key customers • 75: Dr. Reddys Laboratories Ltd. - Segment focus • 76: Emcure Pharmaceuticals Ltd. - Overview • 77: Emcure Pharmaceuticals Ltd. - Product and service • 78: Emcure Pharmaceuticals Ltd. - Key offerings • 79: Emcure Pharmaceuticals Ltd. - Key customers • 80: Emcure Pharmaceuticals Ltd. - Segment focus • 81: GlaxoSmithKline Plc - Overview • 82: GlaxoSmithKline Plc - Business segments • 83: GlaxoSmithKline Plc - Key offerings • 84: GlaxoSmithKline Plc - Key customers • 85: GlaxoSmithKline Plc - Segment focus • 86: Intas Pharmaceuticals Ltd. - Overview • 87: Intas Pharmaceuticals Ltd. - Product and service • 88: Intas Pharmaceuticals Ltd. - Key offerings • 89: Intas Pharmaceuticals Ltd. - Key customers • 90: Intas Pharmaceuticals Ltd. - Segment focus • 91: Macleods Pharmaceuticals Ltd. - Overview • 92: Macleods Pharmaceuticals Ltd. - Product and service • 93: Macleods Pharmaceuticals Ltd. - Key offerings • 94: Macleods Pharmaceuticals Ltd. - Key customers • 95: Macleods Pharmaceuticals Ltd. - Segment focus • 96: Pfizer Inc. - Overview • 97: Pfizer Inc. - Business segments • 98: Pfizer Inc. - Key offerings • 99: Pfizer Inc. - Key customers • 100: Pfizer Inc. - Segment focus • 101: Currency conversion rates for US$ • 102: Research Methodology • 103: Validation techniques employed for market sizing • 104: Information sources • 105: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
TechNavio社のその他分野での最新刊レポート本レポートと同じKEY WORD(kidney)の最新刊レポート
よくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|